National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-18
SponsorNorth-West University, South Africa

About this trial

The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.

Eligibility criteria

Qualifiers

All children between ages 5-<18 years

All children with voluntary assent/consent and parent's permission

Disqualifiers

circumstances interfere with the participant's ability to give informed consent (diminished understanding or comprehension, or any language barriers that may pose potential risk in participation under false expectations)

randomly selected children who choose not to participate (lack of assent/consent), even if parent's permission was received,

conditions that interfere with a patient's ability to follow study guidelines, e.g., the use of drugs, alcohol or tobacco products

ages >18 years or under 5 years

Trial design

Treatments tested in this trial

  • Blood pressure screening

Treatment groups

22,464 Participants
are divided into 2 treatment groups

Sponsors and collaborators

North-West University, South Africa

Lead sponsor

Medical Research Council, South Africa

Collaborator

University of Cape Town

Collaborator

University of Limpopo

Collaborator

Walter Sisulu University

Collaborator

University of KwaZulu

Collaborator

Red Cross War Memorial Childrens Hospital

Collaborator

University of Witwatersrand, South Africa

Collaborator

University of Zurich

Collaborator

Groote Schuur Hospital

Collaborator

Nelson Mandela Metropolitan University

Collaborator

Chris Hani Baragwanath Academic Hospital

Collaborator

University of the Free State

Collaborator